MX9201782A - Particulas de sustancias biologicamente activas, sustancialmente insolubles en agua, proceso para su produccion y composicion farmaceutica que las contiene. - Google Patents
Particulas de sustancias biologicamente activas, sustancialmente insolubles en agua, proceso para su produccion y composicion farmaceutica que las contiene.Info
- Publication number
- MX9201782A MX9201782A MX9201782A MX9201782A MX9201782A MX 9201782 A MX9201782 A MX 9201782A MX 9201782 A MX9201782 A MX 9201782A MX 9201782 A MX9201782 A MX 9201782A MX 9201782 A MX9201782 A MX 9201782A
- Authority
- MX
- Mexico
- Prior art keywords
- particles
- production
- water
- pharmaceutical composition
- biologically active
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4112854 | 1991-04-19 | ||
| DE4113016 | 1991-04-20 | ||
| DE4113343 | 1991-04-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX9201782A true MX9201782A (es) | 1992-10-01 |
Family
ID=27202407
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9201782A MX9201782A (es) | 1991-04-19 | 1992-04-15 | Particulas de sustancias biologicamente activas, sustancialmente insolubles en agua, proceso para su produccion y composicion farmaceutica que las contiene. |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP0580690B2 (es) |
| JP (1) | JP3695754B2 (es) |
| AT (1) | AT410896B (es) |
| AU (1) | AU1577992A (es) |
| CA (1) | CA2108018C (es) |
| DE (1) | DE4291156T1 (es) |
| ES (1) | ES2069995T5 (es) |
| FR (1) | FR2675382B1 (es) |
| GB (1) | GB2269536B (es) |
| IE (1) | IE921230A1 (es) |
| IL (1) | IL101635A0 (es) |
| IT (1) | IT1254323B (es) |
| MX (1) | MX9201782A (es) |
| NO (1) | NO933695D0 (es) |
| WO (1) | WO1992018105A1 (es) |
| ZA (1) | ZA922834B (es) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH686761A5 (de) | 1993-05-27 | 1996-06-28 | Sandoz Ag | Galenische Formulierungen. |
| PT729353E (pt) * | 1993-11-19 | 2002-07-31 | Alkermes Inc | Preparacao de microparticulas biodegradaveis contendo um agente biologicamente activo |
| ATE274341T1 (de) | 1995-02-24 | 2004-09-15 | Elan Pharma Int Ltd | Nanopartikel-dispersionen enthaltende aerosole |
| US5766629A (en) * | 1995-08-25 | 1998-06-16 | Sangstat Medical Corporation | Oral cyclosporin formulations |
| US5834017A (en) * | 1995-08-25 | 1998-11-10 | Sangstat Medical Corporation | Oral cyclopsporin formulations |
| US5827822A (en) * | 1996-03-25 | 1998-10-27 | Sangstat Medical Corporation | Cyclosporin a formulations as nanoparticles |
| US5962019A (en) * | 1995-08-25 | 1999-10-05 | Sangstat Medical Corporation | Oral cyclosporin formulations |
| GB9601120D0 (en) | 1996-01-19 | 1996-03-20 | Sandoz Ltd | Organic compounds |
| TW497974B (en) * | 1996-07-03 | 2002-08-11 | Res Dev Foundation | High dose liposomal aerosol formulations |
| US6465016B2 (en) | 1996-08-22 | 2002-10-15 | Research Triangle Pharmaceuticals | Cyclosporiine particles |
| US6337092B1 (en) | 1998-03-30 | 2002-01-08 | Rtp Pharma Inc. | Composition and method of preparing microparticles of water-insoluble substances |
| AU761205B2 (en) | 1998-03-30 | 2003-05-29 | Skyepharma Canada Inc. | Composition and method of preparing microparticles of water-insoluble substances |
| DE19821951A1 (de) * | 1998-05-15 | 1999-11-18 | Basf Ag | Cyclosporin-Zubereitungen |
| ES2216517T3 (es) | 1998-05-29 | 2004-10-16 | Skyepharma Canada Inc. | Composiciones de microcapsulas termoprotegidas y procedimiento para su esterilizacion terminal con vapor. |
| EP1133281A1 (en) | 1998-11-20 | 2001-09-19 | RTP Pharma Inc. | Dispersible phospholipid stabilized microparticles |
| US6656504B1 (en) * | 1999-09-09 | 2003-12-02 | Elan Pharma International Ltd. | Nanoparticulate compositions comprising amorphous cyclosporine and methods of making and using such compositions |
| US8586094B2 (en) | 2000-09-20 | 2013-11-19 | Jagotec Ag | Coated tablets |
| US7008644B2 (en) * | 2002-03-20 | 2006-03-07 | Advanced Inhalation Research, Inc. | Method and apparatus for producing dry particles |
| GB0216700D0 (en) | 2002-07-18 | 2002-08-28 | Astrazeneca Ab | Process |
| GB0302673D0 (en) | 2003-02-06 | 2003-03-12 | Astrazeneca Ab | Pharmaceutical formulations |
| KR20120107533A (ko) | 2005-11-28 | 2012-10-02 | 마리누스 파마슈티컬스 | ｇａｎａｘｏｌｏｎｅ 제형, 이의 제조방법 및 용도 |
| CA2669392C (en) | 2006-11-17 | 2016-05-10 | Abbott Gmbh & Co. Kg | Nanocrystals for use in topical cosmetic formulations and method of production thereof |
| EP2101735A2 (en) | 2006-11-28 | 2009-09-23 | Marinus Pharmaceuticals, Inc. | Nanoparticulate formulations and methods for the making and use thereof |
| HU230862B1 (hu) | 2008-04-28 | 2018-10-29 | DARHOLDING Vagyonkezelő Kft | Berendezés és eljárás nanorészecskék folyamatos üzemű előállítására |
| GB201410869D0 (en) * | 2014-06-18 | 2014-07-30 | Perioc Ltd | Novel pharmaceutical formulations and their use in the treatment of periodontal disease |
| CN107106641B (zh) | 2014-10-31 | 2021-12-21 | 葛兰素史密斯克莱知识产权发展有限公司 | 粉末制剂 |
| JP2018530585A (ja) | 2015-10-16 | 2018-10-18 | マリナス ファーマシューティカルズ インコーポレイテッド | ナノ粒子を含む注射可能な神経ステロイド製剤 |
| BR112019002538A2 (pt) | 2016-08-11 | 2019-05-21 | Ovid Therapeutics Inc. | uso de uma composição farmacêutica compreendendo um modulador alostérico, uso de uma composição farmacêutica compreendendo garboxadol ou um sal farmaceuticamente aceitável do mesmo, e composição farmacêutica para a administração parenteral |
| US10391105B2 (en) | 2016-09-09 | 2019-08-27 | Marinus Pharmaceuticals Inc. | Methods of treating certain depressive disorders and delirium tremens |
| WO2020118142A1 (en) | 2018-12-07 | 2020-06-11 | Marinus Pharmaceuticals, Inc. | Ganaxolone for use in prophylaxis and treatment of pospartum depression |
| CN114728012A (zh) | 2019-08-05 | 2022-07-08 | 马瑞纳斯制药公司 | 用于治疗癫痫持续状态的加奈索酮 |
| CN114828889A (zh) | 2019-12-06 | 2022-07-29 | 马瑞纳斯制药公司 | 用于治疗结节性硬化症的加奈索酮 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1532993A (en) * | 1975-03-07 | 1978-11-22 | Beecham Group Ltd | Injectable antibiotic compositions |
| US4963367A (en) * | 1984-04-27 | 1990-10-16 | Medaphore, Inc. | Drug delivery compositions and methods |
| CA1282405C (en) * | 1984-05-21 | 1991-04-02 | Michael R. Violante | Method for making uniformly sized particles from water-insoluble organic compounds |
| US5002940A (en) * | 1984-11-06 | 1991-03-26 | Ciba-Geigy Corporation | Solid drug formulations and stable suspensions |
| CH673395A5 (es) * | 1987-01-30 | 1990-03-15 | Ciba Geigy Ag | |
| CA1323306C (en) * | 1987-03-05 | 1993-10-19 | Mircea C. Popescu | Pharmacological agent-lipid solution preparation |
| US4963362A (en) † | 1987-08-07 | 1990-10-16 | Regents Of The University Of Minnesota | Freeze-dried liposome mixture containing cyclosporin |
| GB2230440B (en) † | 1989-02-09 | 1993-05-19 | Sandoz Ltd | Novel cyclosporin galenic forms |
-
1992
- 1992-04-15 MX MX9201782A patent/MX9201782A/es unknown
- 1992-04-16 WO PCT/EP1992/000862 patent/WO1992018105A1/en active IP Right Grant
- 1992-04-16 DE DE4291156T patent/DE4291156T1/de not_active Withdrawn
- 1992-04-16 IT ITRM920281A patent/IT1254323B/it active
- 1992-04-16 ES ES92908795T patent/ES2069995T5/es not_active Expired - Lifetime
- 1992-04-16 JP JP50799892A patent/JP3695754B2/ja not_active Expired - Lifetime
- 1992-04-16 ZA ZA922834A patent/ZA922834B/xx unknown
- 1992-04-16 AU AU15779/92A patent/AU1577992A/en not_active Withdrawn
- 1992-04-16 AT AT0901092A patent/AT410896B/de not_active IP Right Cessation
- 1992-04-16 GB GB9319585A patent/GB2269536B/en not_active Expired - Fee Related
- 1992-04-16 CA CA002108018A patent/CA2108018C/en not_active Expired - Fee Related
- 1992-04-16 EP EP92908795A patent/EP0580690B2/en not_active Expired - Lifetime
- 1992-04-16 IE IE123092A patent/IE921230A1/en unknown
- 1992-04-17 FR FR9204817A patent/FR2675382B1/fr not_active Expired - Fee Related
- 1992-04-17 IL IL101635A patent/IL101635A0/xx unknown
-
1993
- 1993-10-14 NO NO933695A patent/NO933695D0/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GB9319585D0 (en) | 1993-12-15 |
| ITRM920281A0 (it) | 1992-04-16 |
| FR2675382B1 (fr) | 1995-05-12 |
| ZA922834B (en) | 1993-10-18 |
| EP0580690B2 (en) | 2000-09-13 |
| ATA901092A (de) | 2003-01-15 |
| GB2269536B (en) | 1995-05-10 |
| IE921230A1 (en) | 1992-10-21 |
| CA2108018A1 (en) | 1992-10-20 |
| EP0580690A1 (en) | 1994-02-02 |
| WO1992018105A1 (en) | 1992-10-29 |
| ITRM920281A1 (it) | 1993-10-16 |
| NO933695D0 (no) | 1993-10-14 |
| JP3695754B2 (ja) | 2005-09-14 |
| IT1254323B (it) | 1995-09-14 |
| IL101635A0 (en) | 1992-12-30 |
| DE4291156T1 (de) | 1994-10-20 |
| GB2269536A (en) | 1994-02-16 |
| EP0580690B1 (en) | 1995-03-15 |
| AT410896B (de) | 2003-08-25 |
| ES2069995T5 (es) | 2000-11-16 |
| AU1577992A (en) | 1992-11-17 |
| FR2675382A1 (fr) | 1992-10-23 |
| ES2069995T3 (es) | 1995-05-16 |
| JPH06506926A (ja) | 1994-08-04 |
| CA2108018C (en) | 2003-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9201782A (es) | Particulas de sustancias biologicamente activas, sustancialmente insolubles en agua, proceso para su produccion y composicion farmaceutica que las contiene. | |
| MX9102353A (es) | N,o-sulfados de heparosanos, su procedimiento de preparacion y las composiciones farmaceuticas que contienen. | |
| BR9510302A (pt) | Forma de dosagem farmacêutical de liberação controlada método para tratamento sintomático da tosse método para preparar uma forma de dosagem farmacêutica de liberação controlada composição para uso no tratamento sintomático da tosse e aplicação de uma forma dosagem de moguisteina de liberação controlada | |
| ATA249588A (de) | 4h-1-benzopyran-4-on-derivate oder deren salze, verfahren zur herstellung derselben und pharmazeutische zusammensetzung, welche dieselben als wirkstoff enthalten | |
| BR9611410A (pt) | Método e composição farmacêutica para regular a concentração de lipídios | |
| MX9101504A (es) | Metodo y composicion para aumentar la acumulacion de esterol en plantas superiores. | |
| FR2612187B1 (fr) | Derives du thiazole actifs sur le systeme cholinergique, leur procede de preparation et compositions pharmaceutiques en contenant | |
| DE69014351T2 (de) | Pyridincarbonsäureamid-Derivate und diese enthaltende pharmazeutische Zusammensetzungen. | |
| MX9101035A (es) | Quinazolinonas biologicamente activas y composicion farmaceutica que las contiene | |
| DE4495520T1 (de) | Verfahren und pharmazeutische Zusammensetzung zum zielgerichten Anwenden von Wirkstoffen | |
| FR2663326B2 (fr) | Derives de la pyridazine, procede de preparation et compositions pharmaceutiques en contenant. | |
| KR950701924A (ko) | 신규한 생물학적으로 활성인 에부르나메닌 유도체 및 그 유도체가 함유된 약제학적 조성물과 그 제조방법 | |
| DK159413C (da) | Farmaceutisk produkt til kontrolleret afgivelse af aktive stoffer til huden og fremgangsmaade til fremstilling deraf | |
| IT8323058A0 (it) | Derivati di 2,5-piperazindione biologicamente attivi, processi per la loro preparazione e composizioni farmaceutiche che licontengono. | |
| MC2050A1 (fr) | Derives de benzopyrannols,compositions pharmaceutiques les contenant et procede de fabrication | |
| FR2700956B1 (fr) | Composition cosmetique et pharmaceutique et procede pour sa preparation. | |
| EE03440B1 (et) | Bioloogilise toimega bensotiasolooni etaanamiinid ja nende valmistamise protsess | |
| ATE136465T1 (de) | Verwendung von gibberellinen zur herstellung eines arzneimittels zur behandlung von prostatitis | |
| FR2675806B1 (fr) | Polysaccharides sulfates, procede de preparation, composition pharmaceutique et utilisation. | |
| MA19907A1 (fr) | Procede de preparation de derives de la thiatriazine et utilisation de ceux-ci dans des compositions pharmaceutiques. | |
| IT8519907A0 (it) | Prodotto farmaceutico cosmetico, in particolare per la cura di acne e seborrea. | |
| MA19893A1 (fr) | Procede de preparation de derives de sulfamoylbenzophenone et utilisation de ceux-ci dans des compositions pharmaceutiques. | |
| NO944809L (no) | Biologisk aktive ureidoderivater som er nyttig i behandling av lentivirus-indusert sykdom | |
| FI960740A0 (fi) | Substituoituja bentseenisulfonyyliureoita ja -tioureoita, menetelmä niiden valmistamiseksi, niiden käyttö farmaseuttisten valmisteiden valmistukseen ja niitä sisältäviä lääkkeitä | |
| BR9505528A (pt) | Composotos processo para sua produção preparações farmacéuticas seu uso e método para o tratamento de desordens que estáo associadas com atividades de endotelina |